Apollo Hospitals Enterprise Ltd Share Price Today - Apollo Hospitals Enterprise Ltd Stock Price Live NSE/BSE

Apollo Hospitals Enterprise Ltd

NSE: APOLLOHOSP BSE: 508869

₹7542.50

(0.05%)

Sat, 14 Feb 2026, 02:17 am

MTF 5xInvest in Apollo Hospitals Enterprise Ltd with 5x Leverage Buy with MTF

Market Cap1083.73B

PE Ratio60.19

Dividend0.25

Health Services

Hospital/Nursing Management

24.5K

Apollo Hospitals Enterprise Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
108388.47
Net Profit
1505.10
P/B
11.61
Sector P/E
57.52
P/E
65.86
EV/EBITDA
30.50
Debt/Equity (Industry)
0.46
Interest Cover (Industry)
7.69
ROCE (Industry)
16.47
RONW (Industry)
18.26
ROE
19.89
ROCE
17.49
Debt/Equity
0.61
EPS (TTM)
126.33
Dividend Yield
0.17
Book Value
631.88
Interest Cover
5.45

Analysis

all

Pros

Dividends per share have increased over the past 10 years.
Dividends paid are well covered by earnings (3.8x coverage).
Dividends after 3 years are expected to be well covered by earnings (4.5x coverage).
Dividends per share have been stable in the past 10 years.
Apollo Hospitals Enterprise's earnings are expected to grow significantly at over 20% yearly.

Cons

Apollo Hospitals Enterprise's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Apollo Hospitals Enterprise's dividend is below the markets top 25% of dividend payers in India (3.08%).
Cash flow for Apollo Hospitals Enterprise is expected to increase but not above the 50% threshold in 2 years time.
Apollo Hospitals Enterprise's earnings are expected to increase but not above the low risk growth rate next year.
Apollo Hospitals Enterprise is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	28.02	28.02	29.34	29.34	29.33
FII	43.54	44.20	43.49	42.74	45.27
DII	21.51	21.12	21.34	22.29	19.98
Public	6.71	6.43	5.61	5.41	5.19
Government	0.23	0.23	0.23	0.23	0.23

Technical Analysis

RSI

71.67

MACD

90.46

50 DMA

7107.63

200 DMA

7336.31

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	8631.33	7839.83	7400.17	7048.33	6608.67	6256.83	5465.33
Fibonacci	7839.83	7537.48	7350.69	7048.33	6745.98	6559.19	6256.83
Camarilla	7178.16	7105.61	7033.05	7048.33	6887.95	6815.39	6742.84

Pivots Level: Classic

+1583.00

8631.33

+791.50

7839.83

+351.83

7400.17

7048.33

Pivot Point

LTP: 7542.50

-439.67

6608.67

-791.50

6256.83

-1583

5465.33

Moving Average

SMAEMA

Period

Value

10-EMA
7293.88
20-EMA
7190.31
30-EMA
7165.87
50-EMA
7186.22
100-EMA
7259.50
200-EMA
7232.82

Announcement Date	Purpose	Action	Ex Date
10 Feb 2026	dividend	₹10.00 Dividend /Share	16 Feb 2026
10 Feb 2026	board-meetings	Quarterly Results
06 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
30 May 2025	dividend	₹10.00 Dividend /Share	19 Aug 2025
30 May 2025	agm
10 Feb 2025	dividend	₹9.00 Dividend /Share	15 Feb 2025
05 Aug 2024	agm
30 May 2024	dividend	₹10.00 Dividend /Share	17 Aug 2024
08 Feb 2024	dividend	₹6.00 Dividend /Share	20 Feb 2024
30 May 2023	dividend	₹9.00 Dividend /Share	19 Aug 2023

Apollo Hospitals Enterprise Ltd

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd

Aster DM Healthcare Ltd

Global Health Ltd

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd About

Apollo Hospitals Enterprise The main business of the Company and its subsidiaries (hereinafter referred to as ‘the Group’) is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis and providing / selling high quality pharma and wellness products through a network of pharmacies, including operation of multidisciplinary private hospitals, clinics,diagonostic centers and pharmacies.

Industry

Healthcare

Founded

1979

Headquarters

CEO

Preetha Reddy

Employees

Contact

Website

http://www.apollohospitals.com

investor.relations@apollohospitals.com

Phone

91-44-28290956/28293896

Location

No 19 Bishop Garden, Raja Annamalaipuram, Chennai, Tamil Nadu, 600028

Year	History
2020	Launched Sanjeevani Telehealth Seva for non-COVID patients in Bhopal.
2021	Partnered with Anatomiz3D to establish 3D printing labs across several facilities.
2022	Partnered with Balmer Healthcare to set up tertiary care hospital in Kenya. Launched automated AI-based real-time rapid-response patient monitoring system, Enhanced Connected Care. Performed novel interventional procedures to save four patients with Atrial Fibrillation at Chennai. Performed world's first Endoscopic Transcanal Excision of Facial Nerve Schwannoma at Apollo Cancer Centre, Bangalore.
2023	Approved detailed expansion plan involving capital outlay of Rs. 34,350 million.
2024	Launched Fatty Liver Clinic at Chennai with cutting-edge diagnostic tools and pharmacological treatments. Apollo Proton Cancer Centre trained international doctors for Proton Beam Therapy in collaboration with Belgium-based IBA. Apollo Proton Cancer Centre unveiled India's first integrated organ and disease-specific programme for rectal cancer management. Apollo Cancer Centres launched Unmask Cancer initiative to tackle societal biases against cancer patients and survivors. Apollo Cancer Centre introduced India's fastest and most precise breast cancer diagnosis program.

Client Name	Order Side	QTY	Avg Price	Date
SUNEETHA REDDY	Sell	1897239	7850	22 Aug 2025

Apollo Hospitals Enterprise Ltd News

Apollo Hospitals Subsidiary Acquires Bangalore Hospital

Imperial Hospital and Research Centre Limited, Apollo Hospitals' subsidiary, completed acquisition of Belenus Champion Hospitals for Rs 1,650 million, expanding 125-bed facility to 175 beds.

10 Feb 2026

co actions results

Apollo Hospitals Q3FY26 Results Show Strong Growth

Apollo Hospitals Enterprise Limited reported strong Q3FY26 results with consolidated revenue growing 17% YoY to Rs. 6,477 crore and PAT increasing 35% YoY to Rs. 502 crore. The company also declared an interim dividend of Rs. 10 per share.

10 Feb 2026

co actions results

Apollo Hospitals Block Trade Worth Rs. 55.83 Crores

Apollo Hospitals Enterprise Ltd. witnessed a significant NSE block trade valued at Rs. 55.83 crores involving approximately 78,657 shares at Rs. 7097.50 per share.

06 Feb 2026

co actions results

Apollo Hospitals Q3 FY26 Earnings Call on Feb 11

Apollo Hospitals Enterprise Limited announces conference call for analysts and investors on February 11, 2026 at 2:00 PM IST to discuss Q3 FY26 financial results for quarter ended December 31, 2025.

30 Jan 2026

co actions results

Apollo Hospitals Gets AA+ Rating Reaffirmation

CRISIL reaffirms Apollo Hospitals' AA+ rating with positive outlook revision for Rs. 2800 crores bank facilities and Rs. 19 crores debentures, citing strong market position and improving financials.

27 Jan 2026

stocks

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800